Acute Leukemia — Trials

Acute Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

4,655 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,259
Recruiting: 759
Ph III recruiting: 70
Growth YoY: −1.5%
Industry share: 16%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 36.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (720)

clinicaltrialsPublishedShowing 451–500 of 4,655 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02101853	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia	active not recruiting	Phase 3	669	National Cancer Institute (NCI)NIH	5	Jul 29, 2026	clinicaltrials
NCT02112916	Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma	active not recruiting	Phase 3	847	National Cancer Institute (NCI)NIH	4	Jul 29, 2026